CEBPA and acute myeloid leukemia: However, there were some differences between mutation patterns of AML among Asian and Western populations; the mutations of NPM1, FLT3-ITD, FLT3-tyrosine kinase domain (TKD) and CEBPA were found in 16% (Asian) versus 30% (Western), 11% (Asian) versus 23% (Western), 9% (Asian) versus 10% (Western) and 21% (Asian) versus 9% (Western), respectively [6].